OPPENHEIMER ASSET MANAGEMENT INC. - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 174 filers reported holding ASCENDIS PHARMA A/S in Q2 2021. The put-call ratio across all filers is 4.45 and the average weighting 0.4%.

Quarter-by-quarter ownership
OPPENHEIMER ASSET MANAGEMENT INC. ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q2 2024$944,704
+28.1%
6,927
+42.0%
0.01%
+9.1%
Q1 2024$737,558
+17.0%
4,879
-2.6%
0.01%
+22.2%
Q4 2023$630,632
+27.5%
5,007
-5.2%
0.01%
+12.5%
Q3 2023$494,794
-0.5%
5,284
-5.1%
0.01%
+14.3%
Q2 2023$497,123
-19.9%
5,570
-3.7%
0.01%
-30.0%
Q1 2023$620,482
-13.7%
5,787
-1.7%
0.01%
-16.7%
Q4 2022$719,346
-6.8%
5,890
-21.2%
0.01%
-14.3%
Q3 2022$772,000
+7.1%
7,476
-3.6%
0.01%
+16.7%
Q2 2022$721,000
-45.9%
7,757
-31.7%
0.01%
-36.8%
Q1 2022$1,333,000
-17.9%
11,359
-5.9%
0.02%
-13.6%
Q4 2021$1,624,000
-22.8%
12,074
-8.5%
0.02%
-26.7%
Q3 2021$2,103,000
+55.5%
13,195
+28.4%
0.03%
+57.9%
Q2 2021$1,352,000
+34.1%
10,277
+31.4%
0.02%
+18.8%
Q1 2021$1,008,000
+34.8%
7,823
+74.5%
0.02%
+33.3%
Q4 2020$748,000
+106.1%
4,484
+90.7%
0.01%
+71.4%
Q3 2020$363,000
+81.5%
2,351
+73.5%
0.01%
+75.0%
Q2 2020$200,000
+308.2%
1,355
+210.1%
0.00%
+300.0%
Q1 2020$49,0004370.00%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q2 2021
NameSharesValueWeighting ↓
Vivo Capital, LLC 2,003,147$225,574,00020.44%
RA Capital Management 4,914,955$553,473,00017.48%
Sofinnova Investments, Inc. 1,109,874$124,983,00011.56%
Eversept Partners, LP 275,494$31,023,3797.71%
Avoro Capital Advisors LLC 1,787,000$201,234,0006.79%
Orbimed Advisors 3,287,400$370,194,0006.22%
Eventide Asset Management 1,698,648$191,285,0006.19%
Logos Global Management LP 120,000$13,513,0005.14%
Ghost Tree Capital, LLC 150,000$16,892,0004.48%
Spyglass Capital Management LLC 351,388$39,570,0004.47%
View complete list of ASCENDIS PHARMA A/S shareholders